KLHL22 maintains PD-1 homeostasis and prevents excessive T cell suppression

Xiao Albert Zhou(Peking University), Jiadong Wang(Peking University), Long Zhao(Peking University), Guihui Yu(Peking University), Ruoshi Yuan(Peking University), Yingjiang Ye(Peking University), Zhanlong Shen(Peking University People's Hospital), Yan Wang(Shandong Provincial QianFoShan Hospital), Wei Wang(Zhuhai People's Hospital), Weibin Wang(Peking University), Wenjia Zhang(Yunnan University), Jiadong Zhou(Peking University), Changfeng Chen(Peking University), Jun Zhan(Peking University), Donghao Xu(Peking University), Chanyi Shi(Peking University)
Proceedings of the National Academy of Sciences
October 27, 2020
10.1073/pnas.2004570117
Cited by 80

Related Papers

Single-Cell Analyses Inform Mechanisms of Myeloid-Targeted Therapies in Colon Cancer
|Cell|2020|1.6k
Lineage tracking reveals dynamic relationships of T cells in colorectal cancer
|Nature|2018|1.5k
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial
|The Lancet Oncology|2021|436
Short-term outcomes of complete mesocolic excision versus D2 dissection in patients undergoing laparoscopic colectomy for right colon cancer (RELARC): a randomised, controlled, phase 3, superiority trial
|The Lancet Oncology|2021|184
A Multicenter Study on Etiology of Acute Pancreatitis in Beijing During 5 Years
|Pancreas|2014|147